Ryan Craig, MD, PhD

Assistant Professor

Director, Residency Program
School of Medicine
Ryan Craig, MD, PhD

Education & Affiliations

2018-2019 University of Utah, Department of Hematopathology, Hematopathology Fellow
2014-2018 University of Utah, Department of Pathology, AP/CP Resident
2006-2014 Louisiana State University Health Sciences Center – New Orleans / Ph.D. in Microbiology/Immunology (August 2012) / M.D. (May 2014)
2004-2006 Louisiana State University, School of Veterinary Medicine – Baton Rouge M.S. in Comparative Biomedical Sciences, May 2006
2000-2004 Louisiana State University – Baton Rouge B.S. in Biological Sciences with Minor in English Literature, May 2004

Biography

Appointment and Position

2020-present     Module Co-Director for Phase I Fundamentals of Human Biology (Tulane School of Medicine) 

2020-present     Module Co-Director for Phase II Mechanisms of Disease (Tulane School of Medicine) 

2020-present     Pathology Clerkship Director/Pathology Career Advisor for Medical Students 

2019-present     Assistant Program Director for AP/CP Pathology Residency 

2019-present     Assistant Medical Director of Clinical Chemistry 

2019-present     Assistant Professor of Pathology, Tulane University School of Medicine 

Publications

Pincus, S.; Craig, R.; Weachter, L.; LaBranche, C.; Nabi, R.; Watt, C.; Raymond, M.; Peters, T.; Song, K.; Maresh, G.; Montefiori, D.; Kozlowski, P.  Bispecific Anti-HIV Immunoadhesins That Bind gp120 and gp41 Have Broad and Potent HIV-Neutralizing Activity. Vaccines 2021, 9(7), 774. 
 
Ibrahim M, Chen R, Vegel A, Panse K, Bhyravabhotla K, Harris K, Craig R, Safah H, Saba NS, Socola F.  2021.  Treatment of myeloid sarcoma without bone marrow involvement with gemtuzumab ozogamicin-containing regimen.  Leuk Res. 2021 April 22;106:106583 
 
Craig RB, Summa CM, Corti M, Pincus SH.  2012.  Anti-HIV double variable domain immunoglobulins binding both gp41 and gp120 for targeted delivery of immunoconjugates.  PLoS One, 2012;7(10):e46778  
  
Craig R, Cutrera J, Zhu S, Xia X, Lee YH, Li S.  2008.  Administering plasmid DNA encoding tumor vessel-anchored IFN-alpha for localizing gene product within on into tumors.  Molecular Therapy, 2008 May;16(5):901-6.  
  
Craig R, Li S.  2006.  Function and molecular mechanisms of tumor-targeted peptides for delivering therapeutic genes and chemical drugs.  Mini Reviews in Medicinal Chemistry, 2006 Jul;6(7):757-64.